Doxazosin
- Product NDC
- 71610-831
- 11-digit product format
- 716100831
- Labeler code
- 71610
- Product ID
- 71610-831_187bc466-9b63-4ac5-e063-6294a90a7e9b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA208719
- Marketing category
- ANDA
- Marketing start
- 2017-08-31
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 8 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 86P6PQK0MU | DOXAZOSIN MESYLATE | 77883-43-3 | DOXAZOSIN MESYLATE |
| NW1291F1W8 | DOXAZOSIN | 74191-85-8 | Doxazosin |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71610-831-53 | 71610083153 | 60 TABLET in 1 BOTTLE (71610-831-53) | 60 tablet | 2024-05-13 | No | No | Historical |
| 71610-831-60 | 71610083160 | 90 TABLET in 1 BOTTLE (71610-831-60) | 90 tablet | 2024-05-13 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Doxazosin | Aphena Pharma Solutions - Tennessee, LLC | 2024-05-15 | HUMAN PRESCRIPTION DRUG LABEL | 1 |